Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices 28075 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Johnson Matthey Inc. to manufacture 

the listed basic class of controlled 

substance is consistent with the public 

interest at this time. DEA has 

investigated Johnson Matthey Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic class of controlled substance 

listed. 

Dated: May 9, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9639 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated January 23, 2007, and 

published in the Federal Register on 

January 30, 2007, (72 FR 4298), 

Mallinckrodt Inc., 3600 North Second 

Street, St. Louis, Missouri 63147, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedule I and II: 

Drug Schedule 

Codeine-N-oxide (9053) ............... I 

Difenoxin (9168) ........................... I 

Dihydromorphine (9145) ............... I 

Morphine-N-oxide (9307) ............. I 

Norlevorphanol (9634) .................. I 

Normorphine (9313) ..................... I 

Tetrahydrocannabinols (7370) ..... I 

Nabilone (7379) ............................ II 

Alfentanil(9737) ............................ II 

Amphetamine (1100) .................... II 

Ecgonine (9180) ........................... II 

Codeine (9050) ............................. II 

Dextropropoxyphene, bulk(9273) II 

Dihydrocodeine (9120) ................. II 

Diphenoxylate (9170) ................... II 

Diprenorphine (9058) ................... II 

Etorphine HCL (9059) .................. II 

Fentanyl(9801) ............................. II 

Hydrocodone (9193) ..................... II 

Drug Schedule 

Hydromorphone (9150) ................ II 

Levo-alphacetylmethadol (9648) .. II 

Levorphanol(9220) ....................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Metopon (9260) ............................ II 

Morphine (9300) ........................... II 

Opium extracts (9610) .................. II 

Opium fluid extract (9620) ............ II 

Opium tincture (9630) .................. II 

Opium, granulated (9640) ............ II 

Opium, powdered (9639) ............. II 

Oxycodone (9143) ........................ II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Phenazocine (9715) ..................... II 

Alfentanil(9737) ............................ II 

Remifentanil (9739) ...................... II 

Sufentanil(9740) ........................... II 

Thebaine (9333) ........................... II 

The firm plans to manufacture the 

listed controlled substances for internal 

use and for sale to other companies. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Mallinckrodt Inc. to manufacture the 

listed basic class of controlled substance 

is consistent with the public interest at 

this time. DEA has investigated 

Mallinckrodt Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9619 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated February 5, 2007 and 

published in the Federal Register on 

February 12, 2007, (72 FR 6579), 

Mallinckrodt Inc., 3600 North Second 

Street, St. Louis, Missouri 63147, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Phenylacetone (8501) .................. II 

Coca Leaves (9040) ..................... II 

Opium, raw (9600) ....................... II 

Poppy Straw (9650) ..................... II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

listed controlled substances for the 

manufacture of controlled substances in 

bulk for distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Mallinckrodt Inc. to import the basic 

classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated 

Mallinckrodt Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9635 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated August 15, 2006, and 

published in the Federal Register on 

August 22, 2006, (71 FR 48947), 

Noramco Inc., Division of OrthoMcNeil, Inc., 500 Old Swedes Landing 

Road, Wilmington, Delaware 19801, 

made application by renewal, and by 

separate correspondence dated June 2, 


pwalker on PROD1PC71 with NOTICES